Iwasaki Yoji, Talmage David, Starzl Thomas E
Departments of Surgery and Immunology, University of Colorado School of Medicine, and the Denver Veterans Administration Hospital, Denver, Colorado.
Transplantation. 1967 Mar 1;5(2):191-206. doi: 10.1097/00007890-196703000-00008.
Humoral antibodies have been demonstrated by antiglobulin consumption tests to be present in the serum of virtually all patients after renal homotransplantation. The most completely characterized was a γG immunoglobulin distinct from the Forssman antibody which reacts against sheep but not against human red cell antigens, and which absorbs selectively against panels of human liver, kidney or white blood cells. This antibody appeared within a few days or weeks after transplantation, usually shortly after a rejection episode, and was more or less continuously detectable thereafter. The antibody was found in all of 10 patients studied during the first 4 post-transplant months, and in 13 of 14 patients tested from 4 months to more than 2 years after operation. Preliminary observations are included on another humoral antibody which does not react with sheep RBC stromata, but which can also be measured with a modified antiglobulin consumption test. The latter antibody was less commonly demonstrable, but it also exhibited specific absorption characteristics when tested against a panel of leukocytes obtained from volunteers. The implications of these findings are discussed in relation to the possible value of such sera for histocompatibility typing, as well as the possible role of such antibodies in promoting homograft enhancement.
通过抗球蛋白消耗试验已证明,在肾同种移植后,几乎所有患者的血清中都存在体液抗体。特征最完全明确的是一种γG免疫球蛋白,它不同于福斯曼抗体,能与绵羊发生反应,但不与人类红细胞抗原发生反应,并且能选择性地与一组人类肝脏、肾脏或白细胞发生吸收反应。这种抗体在移植后几天或几周内出现,通常在排斥反应发作后不久出现,此后或多或少能持续检测到。在移植后的前4个月内研究的10名患者中,均发现了这种抗体;在术后4个月至2年多接受检测的14名患者中,有13名患者发现了这种抗体。还包括对另一种体液抗体的初步观察结果,该抗体不与绵羊红细胞基质发生反应,但也可用改良的抗球蛋白消耗试验进行检测。后一种抗体较难检测到,但在用从志愿者身上获取的一组白细胞进行检测时,也表现出特异性吸收特征。结合此类血清在组织相容性分型方面的可能价值以及此类抗体在促进同种移植增强方面的可能作用,对这些发现的意义进行了讨论。